Table 1 Demographic and treatment characteristics of AA and non-AA women with symptomatic uterine fibroids treated by MRgFUS
Characteristics | AA (n= 63) | Non-AA (n= 59) | pvaluea |
|---|---|---|---|
Age | Â | Â | 0.001 |
 Mean (SD) | 43.4 (5.1) | 46.3 (4.1) | |
 Median (Q1–Q3) | 44.0 (40.0–47.0) | 46.0 (44.0–49.0) | |
 Min.–max. | 34.0–53.0 | 38.0–53.0 | |
Body mass index (kg/m2) | Â | Â | 0.03 |
 Mean (SD) | 27.7 (4.9) | 25.9 (4.2) | |
 Median (Q1–Q3) | 27.3 (24.1–30.6) | 25.3 (22.5–28.4) | |
 Min.–max. | 18.2–40.7 | 19.1–39.5 | |
Total number of fibroids | Â | Â | <0.001 |
 Mean (SD) | 7.2 (5.4) | 2.8 (2.3) | |
 Median (Q1–Q3) | 6.0 (3.0–10.0) | 2.0 (1.0–4.0) | |
 Min.–max. | 1.0–30.0 | 1.0–11.0 | |
Total volume of fibroids (cm3) | Â | Â | <0.001 |
 Mean (SD) | 273.0 (216.0) | 449.6 (299.6) | |
 Median (Q1–Q3) | 196.9 (112.8–415.3) | 394.8 (189.8–674.4) | |
 Min.–max. | 15.7–807.2 | 18.1–1518.4 | |
Number of treated fibroids | Â | Â | 0.01 |
 Mean (SD) | 1.6 (0.8) | 1.3 (0.6) | |
 Median (Q1–Q3) | 1.0 (1.0–2.0) | 1.0 (1.0–1.0) | |
 Min.–max. | 1.0–4.0 | 1.0–4.0 | |
Total volume of treated fibroids (cm3) | Â | Â | <0.001 |
 Mean (SD) | 177.9 (162.4) | 408.5 (286.6) | |
 Median (Q1–Q3) | 130.0 (64.6–235.0) | 366.6 (183.7–564.0) | |
 Min.–max. | 15.7–700.0 | 18.1–1518.4 | |
NPV ratio per total fibroid | Â | Â | 0.52 |
 Mean (SD) | 28.2 (20.0) | 26.3 (20.7) | |
 Median (Q1–Q3) | 26.0 (15.3–41.0) | 21.0 (9.0–42.0) | |
 Min.–max.ds | 0.0–81.4 | 0.0–79.0 | |
NPV ratio per treated fibroid | Â | Â | 0.03 |
 Mean (SD) | 40.6 (25.4) | 29.9 (23.8) | |
 Median (Q1-Q3) | 37.6 (25.6–55.1) | 27.3 (9.3–48.0) | |
 Min.–max. | 0.0–91.2 | 0.0–94.0 |  |